MicroConstants, a Contract Research Organization focused on regulated bioanalysis and DMPK, has received a 2014 CRO Leadership Award in the areas of quality, regulatory and innovation by Life Science Leader, a global life sciences industry magazine.
Life Science Leader’s annual CRO Leadership Awards are determined by industry-leading market research conducted by Nice Insight. This year, of the 40,000 that were invited to participate, over 10,000 pharmaceutical and biopharmaceutical executives responsible for making or influencing their company’s outsourcing decisions responded to the annual survey. The responses were compiled and analyzed to identify awareness and perception scores for CROs and awards were presented to CROs scoring in the top 20 percent for the following categories – quality, reliability, regulatory, productivity and innovation. Unlike other industry awards, which are given based on a subjective voting or nomination process, the only votes that counted toward the CRO Leadership Awards were those of the pharmaceutical and biopharmaceutical companies using CRO services.
Rob Wright, editor-in-chief at Life Science Leader noted “at Life Science Leader, we think having data-driven awards is more objective and valuable than having those awarded as a result of a nomination and voting process. The winners should be proud of these awards because they were determined by data gathered from customers.”
“For more than 15 years, MicroConstants has aimed to function as an extension of our sponsors’ development teams,” said Gilbert Lam, president and chief scientific officer at MicroConstants. “Constant communication and active participation in our sponsors’ programs has enabled us to suggest critical solutions to their analytical challenges, and anticipate their needs. We are honored that our sponsors have acknowledged our efforts, and awarded us with high marks in the quality, regulatory and innovation categories.”
To view the award issue, please visit Life Science Leader Magazine here.
About MicroConstants, Inc.
MicroConstants is a Contract Research Organization (CRO) focused on performing regulated bioanalysis, drug metabolism and pharmacokinetic analysis in support of new therapeutic development programs. They specialize in method development, GLP method validation and sample analysis for small molecules, macromolecules, biomarkers and metabolites using LC/MS/MS, HPLC/UV, immunoassay, multiplex and qPCR techniques. MicroConstants also assembles and distributes protocol-specific specimen collection kits to streamline and simplify the PK collection process for single and multi-site clinical trials. For more information, please visit http://www.microconstants.com.
For more information, contact:
+1 (858) 652-4600